Concepedia

Trine Saugstrup

TS

Statistics

Publications

4

Citations

722

H-Index

4

Active since

2011

Affiliations

Novo Nordisk (Denmark)(Current)

Trine Saugstrup is an author at Novo Nordisk (Denmark) specializing in medicine, transfusion medicine, and hematology.

Publications per year

2011–2019

4

Publications

4

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

Richard E. Pratley, Aslam Amod, Søren T. Hoff et al. · The Lancet · 2019 · 583 citations

Medicine, Pharmacology, Pharmacotherapy +14

International comparative field study of N8 evaluating factor VIII assay performance

Dorthe Viuff, T W Barrowcliffe, Trine Saugstrup et al. · Haemophilia · 2011 · 67 citations · Full text

Medicine, Hematology, Biopharmaceutics +14

Safety and efficacy of turoctocog alfa (NovoEight<sup>®</sup>) during surgery in patients with haemophilia A: results from the multinational guardian<sup>™</sup> clinical trials

Elena Santagostino, Steven R. Lentz, Mudi Misgav et al. · Haemophilia · 2014 · 50 citations · Full text

Medicine, Hematology, Surgery +14

Safe Application of a Restrictive Transfusion Protocol in Moderate-Risk Patients Undergoing Cardiac Operations

Howard K. Song, Christian von Heymann, Christian M. Jespersen et al. · The Annals of Thoracic Surgery · 2014 · 22 citations · Full text

Medicine, Perioperative Medicine, Surgery +14

1–4 of 4